TR199801797T2 - �ki kutuplu bozukluk tedavisi. - Google Patents

�ki kutuplu bozukluk tedavisi.

Info

Publication number
TR199801797T2
TR199801797T2 TR1998/01797T TR9801797T TR199801797T2 TR 199801797 T2 TR199801797 T2 TR 199801797T2 TR 1998/01797 T TR1998/01797 T TR 1998/01797T TR 9801797 T TR9801797 T TR 9801797T TR 199801797 T2 TR199801797 T2 TR 199801797T2
Authority
TR
Turkey
Prior art keywords
bipolar disorder
disorder treatment
treatment
zapin
seizure
Prior art date
Application number
TR1998/01797T
Other languages
English (en)
Turkish (tr)
Inventor
Merritt Beasley Charles
Dennis Tollefson Gary
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR199801797T2 publication Critical patent/TR199801797T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
TR1998/01797T 1996-03-11 1996-12-04 �ki kutuplu bozukluk tedavisi. TR199801797T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11

Publications (1)

Publication Number Publication Date
TR199801797T2 true TR199801797T2 (xx) 1998-12-21

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01797T TR199801797T2 (xx) 1996-03-11 1996-12-04 �ki kutuplu bozukluk tedavisi.

Country Status (15)

Country Link
EP (1) EP0889725A4 (cs)
JP (1) JP2000506859A (cs)
KR (1) KR19990087713A (cs)
CN (1) CN1213966A (cs)
AU (1) AU734011B2 (cs)
BR (1) BR9612548A (cs)
CZ (1) CZ290298A3 (cs)
EA (1) EA000758B1 (cs)
HU (1) HUP9903679A3 (cs)
IL (1) IL126162A0 (cs)
NO (1) NO984189D0 (cs)
NZ (1) NZ326031A (cs)
PL (1) PL328925A1 (cs)
TR (1) TR199801797T2 (cs)
WO (1) WO1997033577A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101901A3 (en) * 1998-05-22 2002-06-28 Lilly Co Eli Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
BR9911068A (pt) * 1998-05-29 2001-02-06 Lilly Co Eli Terapia combinada para tratamento de distúrbios bipolares
EP1133299A1 (en) 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
JP2002530340A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． オランザピン−ｎ−オキサイドを含む医薬組成物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
CZ290298A3 (cs) 1999-10-13
PL328925A1 (en) 1999-03-01
EA000758B1 (ru) 2000-04-24
HUP9903679A2 (hu) 2000-04-28
NO984189L (no) 1998-09-11
EA199800819A1 (ru) 1999-02-25
JP2000506859A (ja) 2000-06-06
AU734011B2 (en) 2001-05-31
AU1330797A (en) 1997-10-01
NO984189D0 (no) 1998-09-11
HUP9903679A3 (en) 2001-10-29
EP0889725A1 (en) 1999-01-13
IL126162A0 (en) 1999-05-09
WO1997033577A1 (en) 1997-09-18
NZ326031A (en) 2001-05-25
EP0889725A4 (en) 2000-01-19
KR19990087713A (ko) 1999-12-27
BR9612548A (pt) 1999-07-20
CN1213966A (zh) 1999-04-14

Similar Documents

Publication Publication Date Title
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
ES2186874T3 (es) Analogos de m-amidinofenilo como inhibidores del factor xa.
TR200200972T2 (tr) İkameli 2-fenilbenzimidazoller, üretimleri ve kullanımları
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
BG102644A (bg) Подобрени концентрирани инжекционни и инфузионниразтвори за интравазално прилагане
DE60141347D1 (de) Zusammensetzungen zur beseitigung von unangenehmen gerüchen
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
DE602004027251D1 (de) Herstellung von 1,3-diphenylprop-2-en-1-onderivaten
TR200200260T2 (tr) N-desmetilzopiklonlarının üretim ve kullanım yöntemleri
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
TR199801797T2 (xx) �ki kutuplu bozukluk tedavisi.
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
DE3767287D1 (de) Potenzierung von prazosin.
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
MX9708510A (es) Tetralinas.
TR199700547A2 (xx) N-asetonilbenzamid fungisitler.
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
TR200003203T2 (tr) Karboksaldehitin saflaştırılması